Clinical trials for Crohn's disease

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Crohn's disease. For all clinical trials, go to clinical trials search

This list shows clinical trials for Crohn's disease

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Crohn's disease
Title Recruitment status Location
Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab Recruiting United Kingdom
A Study of the Safety and Efficacy of Etrolizumab in Patients With Moderately to Severely Active Crohn's Disease Recruiting United Kingdom
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 Recruiting United Kingdom
Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease Recruiting United Kingdom
A Phase II, Multicenter, Randomized, Double-blind, Multiple Dose, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of BI 655066, an IL-23 p19 Antagonist Monoclonal Antibody, in Patients With Moderately to Severely Active Crohn's Disease, Who Are naïve to, or Were Previously Treated With Anti-TNF Therapy. Recruiting United Kingdom
Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease Recruiting United Kingdom
Vedolizumab Subcutaneous Long-Term Open-Label Extension Study Recruiting United Kingdom
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease Recruiting United Kingdom
A Study to Determine the Safety and Immunogenicity of a Candidate MAP Vaccine ChAdOx2 HAV in Healthy Adult Volunteers Recruiting United Kingdom
BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity Recruiting United Kingdom

Page last reviewed: 17/04/2015

Next review due: 01/04/2018